Fairvalue-Calculator Fairvalue-Calculator
EN DE

Delex Healthcare Group (BNCM) Fair Value & Analysis

Healthcare · US · Market cap $14.0M

Price$0.0059
Fair Value$0.0061
Upside+4.1%
Quality95/100
Evidence: High Range $0.0061 – $0.0067

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Delex Healthcare Group (BNCM) currently trades at $0.0059, while our model-based Fair Value estimate is $0.0061 — implying the stock looks roughly 4.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Delex Healthcare Group Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines. It also engages in the development, distribution, and trading of medical supplies, equipment, pharmaceutical products, and food supplements. In addition, the company offers medical devices and machines, such as cardiovascular ultrasounds; needless connectors and IV lines; and ambulatory/PCA infusion pumps for critical care, anti-infectives, and anesthesia, as well as provides after sales services. It also sells its products through online drugstore. Delex Healthcare Group Inc. was formerly known as Bounce Mobile Systems, Inc. and changed its name to Delex Healthcare Group Inc. in May 2026. The company was founded in 2017 and is based in Quezon City, Philippines.

Open the full interactive analysis →

Similar stocks

Eli Lilly and Company (LLY) -64% Johnson & Johnson, (JNJ) -29% AbbVie Inc (ABBV) -42% Roche Holding (ROGN) -4% Merck & Co (MRCK34) -35% AstraZeneca PLC (A1ZN34) -31%

Frequently asked questions

Is Delex Healthcare Group (BNCM) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0061 versus a price of $0.0059 — about +4% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BNCM?
Our 21-model fair value for Delex Healthcare Group is $0.0061 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0059.
What is the quality score of BNCM?
Delex Healthcare Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.